Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 4.300
+0.382 (9.75%)
Apr 14, 2026, 5:29 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 1.07 billion as of April 14, 2026. Its market cap has increased by 192.52% in one year.
Market Cap
1.07B
Enterprise Value
787.21M
Revenue
316.70M
Ranking
n/a
PE Ratio
7.29
Stock Price
4.30
Market Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 1.07B, an increase of 786.77%. That is a compound annual growth rate of 21.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 974.06M | -6.38% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 2.29B |
| Saniona AB | 2.10B |
| BioInvent International AB | 1.50B |
| Medivir AB | 1.39B |
| Genovis AB (publ.) | 1.31B |
| Xspray Pharma AB | 1.26B |
| SynAct Pharma AB | 1.00B |
| Infant Bacterial Therapeutics AB | 670.20M |